KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) EBIT (2020 - 2025)

Historic EBIT for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to -$90.0 million.

  • Ginkgo Bioworks Holdings' EBIT fell 6306.25% to -$90.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$348.1 million, marking a year-over-year increase of 4511.28%. This contributed to the annual value of -$559.8 million for FY2024, which is 3524.37% up from last year.
  • According to the latest figures from Q3 2025, Ginkgo Bioworks Holdings' EBIT is -$90.0 million, which was down 6306.25% from -$65.5 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' EBIT's 5-year high stood at -$26.7 million during Q3 2021, with a 5-year trough of -$1.7 billion in Q4 2021.
  • For the 5-year period, Ginkgo Bioworks Holdings' EBIT averaged around -$300.3 million, with its median value being -$178.1 million (2023).
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' EBIT tumbled by 291448.43% in 2021, and later skyrocketed by 8629.67% in 2022.
  • Over the past 5 years, Ginkgo Bioworks Holdings' EBIT (Quarter) stood at -$1.7 billion in 2021, then surged by 86.3% to -$230.9 million in 2022, then rose by 22.85% to -$178.1 million in 2023, then skyrocketed by 41.83% to -$103.6 million in 2024, then rose by 13.12% to -$90.0 million in 2025.
  • Its EBIT was -$90.0 million in Q3 2025, compared to -$65.5 million in Q2 2025 and -$89.0 million in Q1 2025.